-
1
-
-
62849085020
-
The challenges faced in the design, conduct and analysis of surgical randomised controlled trials
-
Cook JA. The challenges faced in the design, conduct and analysis of surgical randomised controlled trials. Trials. 2009;10:9.
-
(2009)
Trials
, vol.10
, pp. 9
-
-
Cook, J.A.1
-
2
-
-
33644897345
-
Implementation of a Bayesian adaptive design in a proof of concept study
-
DOI 10.1002/pst.198
-
Smith MK, Jones I, Morris MF, Grieve AP, Tan K. Implementation of a Bayesian adaptive design in a proof of concept study. Pharm Stat. 2006;5:39-50. (Pubitemid 43380267)
-
(2006)
Pharmaceutical Statistics
, vol.5
, Issue.1
, pp. 39-50
-
-
Smith, M.K.1
Jones, I.2
Morris, M.F.3
Grieve, A.P.4
Tan, K.5
-
3
-
-
67649306739
-
Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center
-
Biswas S, Liu DD, Lee JJ, Berry DA. Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center. Clin Trials. 2009;6:205-16.
-
(2009)
Clin Trials
, vol.6
, pp. 205-216
-
-
Biswas, S.1
Liu, D.D.2
Lee, J.J.3
Berry, D.A.4
-
4
-
-
84555178552
-
Seamless phase II/III designs
-
Epub 2010 Aug 19
-
Stallard N, Todd S. Seamless phase II/III designs. Stat Methods Med Res. 2011;20:623-34. Epub 2010 Aug 19.
-
(2011)
Stat Methods Med Res
, vol.20
, pp. 623-634
-
-
Stallard, N.1
Todd, S.2
-
5
-
-
0034020895
-
Trials and fast changing technologies: The case for tracker studies
-
Lilford RJ, Braunholtz DA, Greenhalgh R, Edwards SJ. Trials and fast changing technologies: the case for tracker studies. BMJ. 2000;320:43-6. (Pubitemid 30173019)
-
(2000)
British Medical Journal
, vol.320
, Issue.7226
, pp. 43-46
-
-
Lilford, R.J.1
Braunholtz, D.A.2
Greenhalgh, R.3
Edwards, S.J.L.4
-
6
-
-
0033986821
-
Sample size calculation for clinical trials: The impact of clinician beliefs
-
Fayers PM, Cuschieri A, Fielding J, Craven J, Uscinska B, Freedman LS. Sample size calculation for clinical trials: the impact of clinician beliefs. Br J Cancer. 2000;82:213-9. (Pubitemid 30008984)
-
(2000)
British Journal of Cancer
, vol.82
, Issue.1
, pp. 213-219
-
-
Fayers, P.M.1
Cuschieri, A.2
Fielding, J.3
Craven, J.4
Uscinska, B.5
Freedman, L.S.6
-
7
-
-
0029848245
-
Comments on Bayesian and frequentist analysis and interpretation of clinical trials
-
DOI 10.1016/S0197-2456(96)00043-8, PII S0197245696000438
-
Fisher LD. Comments on Bayesian and frequentist analysis and interpretation of clinical trials. Control Clin Trials. 1996;17:423-34. (Pubitemid 26391664)
-
(1996)
Controlled Clinical Trials
, vol.17
, Issue.5
, pp. 423-434
-
-
Fisher, L.D.1
-
8
-
-
0024842564
-
Comparison of Bayesian with group sequential methods for monitoring clinical trials
-
DOI 10.1016/0197-2456(89)90001-9
-
Freedman LS, Spiegelhalter DJ. Comparison of Bayesian with group sequential methods for monitoring clinical trials. Control Clin Trials. 1989;10:357-67. (Pubitemid 20025666)
-
(1989)
Controlled Clinical Trials
, vol.10
, Issue.4
, pp. 357-367
-
-
Freedman, L.S.1
Spiegelhalter, D.J.2
-
9
-
-
0035806719
-
Monitoring of large randomised clinical trials: A new approach with Bayesian methods
-
DOI 10.1016/S0140-6736(01)05558-1
-
Parmar MK, Griffiths GO, Spiegelhalter DJ, Souhami RL, Altman DG, van der Scheuren E; CHART steering committee. Monitoring of large randomised clinical trials: a new approach with Bayesian methods. Lancet. 2001;358:375-81. (Pubitemid 32739099)
-
(2001)
Lancet
, vol.358
, Issue.9279
, pp. 375-381
-
-
Parmar, M.K.B.1
Griffiths, G.O.2
Spiegelhalter, D.J.3
Souhami, R.L.4
Altman, D.G.5
Van Der, S.E.6
-
11
-
-
0033044884
-
The irrelevance of inference: A decision-making approach to the stochastic evaluation of health care technologies
-
DOI 10.1016/S0167-6296(98)00039-3, PII S0167629698000393
-
Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999;18:341-64. (Pubitemid 29242816)
-
(1999)
Journal of Health Economics
, vol.18
, Issue.3
, pp. 341-364
-
-
Claxton, K.1
-
12
-
-
21044450556
-
The value of information and optimal clinical trial design
-
DOI 10.1002/sim.2069
-
Willan AR, Pinto EM. The value of information and optimal clinical trial design. Stat Med. 2005;24:1791-806. (Pubitemid 40872643)
-
(2005)
Statistics in Medicine
, vol.24
, Issue.12
, pp. 1791-1806
-
-
Willan, A.R.1
Pinto, E.M.2
-
13
-
-
58149130292
-
Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methods
-
Willan A, Kowgier M. Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methods. Clin Trials. 2008;5:289-300.
-
(2008)
Clin Trials
, vol.5
, pp. 289-300
-
-
Willan, A.1
Kowgier, M.2
-
14
-
-
0026164330
-
An essay towards solving a problem in the doctrine of chances. 1763
-
Bayes T. An essay towards solving a problem in the doctrine of chances. 1763. MD Comput. 1991;8:157-71.
-
(1991)
MD Comput
, vol.8
, pp. 157-171
-
-
Bayes, T.1
|